-The Financial Express If you are a risk-averse investor and have been banking on small savings schemes for the purpose of saving and investment as well as building your retirement nest egg, then there is some bad news for you. For, the government has reduced the return on small savings schemes – including Public Provident Fund (PPF), NSC, Kisan Vikas Patra and Senior Citizen Savings Scheme — by 10 basis points....

-The Hindu The long-term benefits of GST are clear — the challenge is to quickly address the short-term obstacles The Goods and Services Tax (GST) is in force from today. The reform, touted as a “game changer” and the “reform of the century”, was deemed worthy of a launch on the midnight of June 30 in the Central Hall of the Parliament. Indeed, one is reminded of the famous speech by Pandit...

-The Hindu It’s complex than elsewhere both in terms of number of RATes and jurisdictions The form of Goods and Services Tax being implemented from July 1 is uniquely Indian, according to former Planning Commission member and former Chairman of the National Statistical Commission Pronab Sen. In an interview to The Hindu, he says the indirect tax regime will make it easier to start a new company, but increases complexity for those...

-The Times of India NEW DELHI: Can mice or fire destroying files be an adequate excuse not to give information under the RTI Act? That's a question that the central information commission has asked officials in response to a complaint filed by an RTI applicant who claimed that he had been denied information by the department concerned on the basis that the files were "missing". The RTI applicant, Virendra Singh Jafna, had...

-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...